BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2271749)

  • 1. Interaction of ethanol, quinidine, and sparteine with the metabolism of nifedipine by Cunninghamella echinulata.
    Foster BC; Wilson DL; McGilveray IJ
    Biopharm Drug Dispos; 1990 Nov; 11(8):735-8. PubMed ID: 2271749
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of sparteine and quinidine on the metabolism of methoxyphenamine by Cunninghamella bainieri.
    Foster BC; Wilson DL; McGilveray IJ
    Xenobiotica; 1989 Apr; 19(4):445-52. PubMed ID: 2750204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of quinidine on the disposition of nifedipine, sparteine, and mephenytoin in humans.
    Schellens JH; Ghabrial H; van der Wart HH; Bakker EN; Wilkinson GR; Breimer DD
    Clin Pharmacol Ther; 1991 Nov; 50(5 Pt 1):520-8. PubMed ID: 1934865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotransformation of 2-, 3-, and 4-methoxy-amphetamines by Cunninghamella echinulata.
    Foster BC; Litster DL; Lodge BA
    Xenobiotica; 1991 Oct; 21(10):1337-46. PubMed ID: 1796610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic disposition of ajmaline.
    Köppel C; Tenczer J; Arndt I
    Eur J Drug Metab Pharmacokinet; 1989; 14(4):309-16. PubMed ID: 2633926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparison of the effects of sparteine, quinidine and nicotine on isolated myocardium of rats and cats].
    FOERSTER W; HOEFKE W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1960; 239():383-92. PubMed ID: 13823657
    [No Abstract]   [Full Text] [Related]  

  • 7. Biotransformation of tri-substituted methoxyamphetamines by Cunninghamella echinulata.
    Foster BC; McLeish J; Wilson DL; Whitehouse LW; Zamecnik J; Lodge BA
    Xenobiotica; 1992 Dec; 22(12):1383-94. PubMed ID: 1494884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of quinidine, iproveratril, lidocaine and sparteine on ECG and circulatory system of the anesthetized cat].
    Reuter N
    Arzneimittelforschung; 1973 Aug; 23(8):1062-4. PubMed ID: 4801027
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacodynamics of a single dose of quinidine during chronic digoxin treatment. A randomized double blind placebo and sparteine--controlled crossover study.
    Belz GG; Aust PE; Doering W; Heinz M; Schneider B
    Eur J Clin Pharmacol; 1982; 22(2):117-22. PubMed ID: 7094981
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug-drug interactions: effect of quinidine on nifedipine binding to human cytochrome P450 3A4.
    Koley AP; Robinson RC; Markowitz A; Friedman FK
    Biochem Pharmacol; 1997 Feb; 53(4):455-60. PubMed ID: 9105395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidation of quinidine by human liver cytochrome P-450.
    Guengerich FP; Müller-Enoch D; Blair IA
    Mol Pharmacol; 1986 Sep; 30(3):287-95. PubMed ID: 3748010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The quinidine-like actions of sparteine on the isolated frog heart.
    GO LU
    Arch Int Pharmacodyn Ther; 1948 Jun; 76(4):367-82. PubMed ID: 18872595
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of certain lupanin alkaloids on post-aconitine arrhythmia of the isolated heart].
    Czarnecka E; Kolińska-Marzec A; Szadowska A
    Acta Pol Pharm; 1967; 24(5):545-8. PubMed ID: 6062764
    [No Abstract]   [Full Text] [Related]  

  • 14. A dose-effect study of the in vivo inhibitory effect of quinidine on sparteine oxidation in man.
    Nielsen MD; Brøsen K; Gram LF
    Br J Clin Pharmacol; 1990 Mar; 29(3):299-304. PubMed ID: 2310654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quinidine kinetics after a single oral dose in relation to the sparteine oxidation polymorphism in man.
    Brøsen K; Davidsen F; Gram LF
    Br J Clin Pharmacol; 1990 Feb; 29(2):248-53. PubMed ID: 2306418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined effects of antiarrhythmic drugs on the experimentally induced fibrillation of isolated rat's atria.
    Lamela M
    Arch Int Pharmacodyn Ther; 1965 Oct; 157(2):442-53. PubMed ID: 5868745
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of pharmacokinetic interaction between nifedipine, sparteine and phenytoin in man.
    Schellens JH; Soons PA; van der Wart JH; Hoevers JW; Breimer DD
    Br J Clin Pharmacol; 1991 Feb; 31(2):175-8. PubMed ID: 2049233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Propranolol metabolism by Cunninghamella bainieri.
    Foster BC; Buttar HS; Qureshi SA; McGilveray IJ
    Xenobiotica; 1989 May; 19(5):539-46. PubMed ID: 2750210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative inotropic effects of tetrodotoxin and seven class 1 antiarrhythmic drugs in relation to sodium channel blockade.
    Honerjäger P; Loibl E; Steidl I; Schönsteiner G; Ulm K
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Feb; 332(2):184-95. PubMed ID: 2422563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethanol inhibits in-vitro metabolism of nifedipine, triazolam and testosterone in human liver microsomes.
    Patki KC; Greenblatt DJ; von Moltke LL
    J Pharm Pharmacol; 2004 Aug; 56(8):963-6. PubMed ID: 15285839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.